コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vents (e.g. parental use of alcohol/tobacco, pregnancy complications).
2 therapeutic options to prevent this serious pregnancy complication.
3 eeclampsia is a potentially life-threatening pregnancy complication.
4 stly European (55.2%), and 14.8% developed a pregnancy complication.
5 assessing a woman's risk of developing this pregnancy complication.
6 ampsia (PE) is a dangerous and unpredictable pregnancy complication.
7 ge-scale biobank data for understanding this pregnancy complication.
8 ces may be related to preeclampsia, a common pregnancy complication.
9 activation may be a culprit in postsurgical pregnancy complications.
10 oembolism or with previous placenta-mediated pregnancy complications.
11 in ICP cases were associated with coexisting pregnancy complications.
12 and/or prevention of inflammation-associated pregnancy complications.
13 pregnant women with prior placenta-mediated pregnancy complications.
14 to the development of preeclampsia and other pregnancy complications.
15 tinct from HCA and not entirely explained by pregnancy complications.
16 e third, and are associated with the risk of pregnancy complications.
17 heparin in the prevention of recurrent late pregnancy complications.
18 ry outcome was a composite end point of late-pregnancy complications.
19 with reduced UBF, even after controlling for pregnancy complications.
20 l tobacco smoke exposure are associated with pregnancy complications.
21 trol (DES) given to their mothers to prevent pregnancy complications.
22 -10 proficiency protects against CpG-induced pregnancy complications.
23 l infections are a well-established cause of pregnancy complications.
24 a good treatment for women with aPL-induced pregnancy complications.
25 oach to antiphospholipid syndrome-associated pregnancy complications.
26 ciation with abnormal placental function and pregnancy complications.
27 identify a new effector of immune-triggered pregnancy complications.
28 e to the placental dysfunction seen in human pregnancy complications.
29 ht contribute to the pathogenesis of certain pregnancy complications.
30 neural tube defects, Alzheimer disease, and pregnancy complications.
31 block C5a-C5a receptor interactions prevent pregnancy complications.
32 sociation between maternal periodontitis and pregnancy complications.
33 , both of which could trigger GBS-associated pregnancy complications.
34 f implantation and placentation lead to many pregnancy complications.
35 l births, outpatient laboratory testing, and pregnancy complications.
36 ent, leading to congenital disease and other pregnancy complications.
37 se characterized by vascular pathologies and pregnancy complications.
38 conclude that FeNOs merit increased study in pregnancy complications.
39 hat may influence general vaginal health and pregnancy complications.
40 the COVID-19 pandemic, as feasible based on pregnancy complications.
41 mmune protection and lead to infertility and pregnancy complications.
42 therapies for the prevention or treatment of pregnancy complications.
43 dations is associated with increased risk of pregnancy complications.
44 ores was generally related to lower risks of pregnancy complications.
45 r, cardiovascular disease, inflammation, and pregnancy complications.
46 lar vesicle (EV) protein biomarkers of early pregnancy complications.
47 r maternal health conditions can all lead to pregnancy complications.
48 e infertility due to pregnancy loss or later pregnancy complications.
49 d route of delivery, labor complications, or pregnancy complications.
50 es cause complement-dependent thrombosis and pregnancy complications.
51 uctive sleep apnea (OSA) are associated with pregnancy complications.
52 of the placenta during healthy pregnancy and pregnancy complications.
53 with diabetes, other medical conditions, or pregnancy complications.
54 lacental development and placenta-associated pregnancy complications.
55 iming to reduce the risk for immune-mediated pregnancy complications.
56 nd to experience higher rates of age-related pregnancy complications.
57 age is associated with an increased risk of pregnancy complications.
58 y, increased risk of metabolic diseases, and pregnancy complications.
59 ntage are associated with increased risks of pregnancy complications.
60 readiness and adequate response to managing pregnancy complications.
61 itoring of risk factors can assist to reduce pregnancy complications.
62 s for COVID-19 overlap with risk factors for pregnancy complications.
63 ental functions is crucial for understanding pregnancy complications.
64 ant expression of host genes associated with pregnancy complications.
65 isorder and GAD do not contribute to adverse pregnancy complications.
66 6 (95% CI, 1.15-3.02) after stillbirth vs no pregnancy complications.
67 itivity is achieved with addition of current pregnancy complications.
68 ower reproductive success and higher risk of pregnancy complications.
69 eloping personalised medicine approaches for pregnancy complications.
70 ities to prevent and treat infection-related pregnancy complications.
71 trophoblasts, reduces the risk of developing pregnancy complications.
72 ising target for therapeutic manipulation of pregnancy complications.
73 but may paradoxically lead to virus-related pregnancy complications.
74 rsal approach for mitigating immune-mediated pregnancy complications.
75 term birth was examined after stratifying by pregnancy complications.
76 tcomes included the live-birth rate and late pregnancy complications.
77 l testing for aneuploidies and prediction of pregnancy complications.
78 he prevention of recurrent placenta-mediated pregnancy complications.
79 arin effectively prevents recurrence of late pregnancy complications, 135 women with previous history
80 male surgeons were more likely to have major pregnancy complications (311 of 692 [48.3%] vs 43 of 158
83 onin reuptake inhibitor (SSRI) treatment and pregnancy complications, accounting for psychiatric diag
85 cularly urogenital pathogens associated with pregnancy complications (Aerococcus christensenii and Ga
86 ase (SCD), little is known about the risk of pregnancy complications among those with sickle cell tra
87 uent long-term maternal morbidity, rendering pregnancy complications an early chronic disease marker.
89 tational diabetes mellitus (GDM) is a common pregnancy complication and a risk factor for the subsequ
90 recommended throughout pregnancy to prevent pregnancy complications and adverse birth outcomes assoc
91 ls of homocysteine (Hcy) are associated with pregnancy complications and adverse neonatal outcomes, s
92 s (GDM) is associated with increased risk of pregnancy complications and adverse perinatal outcomes.
93 l histology are frequently reported in these pregnancy complications and are often based upon scoring
94 xamined associations between cardiometabolic pregnancy complications and autism spectrum disorder (AS
97 on revealed significant associations between pregnancy complications and both substance use (OR 6.47,
98 milial aggregation of common determinants of pregnancy complications and cardiovascular disease is th
100 patients who gave birth (76.9%; 170 babies), pregnancy complications and congenital anomalies occurre
101 nfection during pregnancy is associated with pregnancy complications and developmental and neurologic
103 anism underlying maternal smoking-associated pregnancy complications and developmental disorders.
106 CVD prevention, as well as the link between pregnancy complications and future CVD risk, were identi
107 uctive failure linking subfertility and late pregnancy complications and has allowed us to reject pra
108 whether there was mediation by diagnoses of pregnancy complications and health behaviors during preg
110 he known roles of Aire-deficiency related to pregnancy complications and infertility, review the newl
111 ta/increta/percreta is associated with major pregnancy complications and is thought to be becoming mo
112 ar mixed-effects models showed that maternal pregnancy complications and low birth weight and prematu
114 We aimed to present an overview of reported pregnancy complications and neonatal sequelae of materna
115 n this population include the higher risk of pregnancy complications and peripartum psychiatric probl
116 hed a mouse model that provided evidence for pregnancy complications and placental anti-angiogenesis
117 is crucial in understanding the etiology of pregnancy complications and prevention of congenital inf
118 immunity, often asymptomatic, and linked to pregnancy complications and risk of viral infection.
120 atios characterized the relationship between pregnancy complications and subsequent hospitalization f
121 is an association between a broader array of pregnancy complications and the future risk of CVD.
122 t biology and sheds light on the etiology of pregnancy complications and the in utero programming of
124 nition may have relevance to immune-mediated pregnancy complications and to tumour immune evasion.
127 dividuals with CVD are at increased risk for pregnancy complications, and management of this unique p
128 stment for sociodemographic characteristics, pregnancy complications, and paternal BMI and were not m
129 of counseling BMT patients about fertility, pregnancy complications, and potential birth defects is
131 ty, insurance, prepregnancy body mass index, pregnancy complications, and smoking or drinking during
132 terine growth restriction (IUGR) are serious pregnancy complications, and the triggers and mediators
133 cental infections represent a major cause of pregnancy complications, and yet the underlying molecula
134 w birth weight infants or who suffer related pregnancy complications are also at increased risk.
137 study were to determine whether PDG-induced pregnancy complications are associated with placental ap
143 n, and gestational diabetes, the most common pregnancy complications, are associated with substantial
144 es, in particular better prophylaxis of late pregnancy complications, are urgently needed for obstetr
145 ndings have implications for immune-mediated pregnancy complications, as well as for our general unde
147 POINTS: Chronic fetal hypoxaemia is a common pregnancy complication associated with intrauterine grow
148 Gestational diabetes mellitus is a common pregnancy complication associated with significant adver
149 psia and gestational hypertension are common pregnancy complications associated with adverse maternal
150 ental nutrient transport and fetal growth in pregnancy complications associated with altered maternal
151 s study, we examine the role of TNF-alpha in pregnancy complications associated with aPL Abs in a mur
152 ew insights in understanding and alleviating pregnancy complications associated with gestational hypo
155 nd B cell dysfunction has been implicated in pregnancy complications associated with PTL, the functio
156 ctives were to describe the epidemiology and pregnancy complications associated with severe ICP and t
158 lms tumor (WT) diagnosed during childhood on pregnancy complications, birth weight, and the frequency
159 ntify not only a subset of women at risk for pregnancy complications but also women with greater card
160 atosus (SLE) have fewer live births and more pregnancy complications, but can have successful live bi
162 urrent, especially severe, placenta-mediated pregnancy complications, but further research is require
163 Maternal asthma is associated with serious pregnancy complications, but newborn morbidity is unders
164 ma) and interleukin-17 (IL-17) are linked to pregnancy complications, but the regulation of maternal
165 There are effective treatments for these pregnancy complications, but they require early detectio
166 ggested to play a role in the development of pregnancy complications, but very little is known about
167 n, leading to infertility, or predisposes to pregnancy complications by rendering the feto-maternal i
170 as chronic infections, autoimmune diseases, pregnancy complications, cancers, and transplant failure
171 or cell hierarchy and may help us understand pregnancy complications caused by a defective placental
172 characteristics, maternal comorbidities, and pregnancy complications), CD was associated with higher
174 Preeclampsia (PE) is a severe multisystem pregnancy complication characterized by gestational hype
176 ytopoiesis and platelet production following pregnancy complications characterized by placental insuf
177 LMWH had recurrent severe placenta-mediated pregnancy complications compared with 127 (42.9%) of 296
179 er of pregnancy were at higher risk of major pregnancy complications compared with those operating le
180 ntenatally based on a combination of current pregnancy complications, congenital anomalies, maternal
181 ia during pregnancy has been associated with pregnancy complications; data on efficacy of recommended
185 increased habitual spontaneous abortion and pregnancy complications (eg, placental abruption and pre
186 ndering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV
190 after adjustments for lifestyle factors and pregnancy complications, highest compared with lowest te
191 nfections are a leading preventable cause of pregnancy complications impacting both mother and fetus.
193 oman with recurrent severe placenta-mediated pregnancy complications in her 2 pregnancies asks: Will
194 also shed light on the pathogenesis of many pregnancy complications in human, such as recurrent spon
197 bolism, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thromboph
198 understanding the role of fetal NK cells in pregnancy complications in which NK cells could be invol
199 novel mechanism of pathogenesis for certain pregnancy complications in which there is engagement of
201 ts of low-molecular-weight heparin (LMWH) on pregnancy complications in women with prior pregnancy lo
202 t heparins are widely used to try to prevent pregnancy complications.In this issue of Blood, Martinel
206 Inferior trophoblast invasion results in pregnancy complications including preeclampsia, intraute
207 erine artery are strongly implicated in many pregnancy complications, including advanced maternal age
208 evelopment and function may result in severe pregnancy complications, including fetal growth restrict
209 o gain insights into the aetiology of common pregnancy complications, including intra-uterine growth
210 dation, hearing loss, visual impairment, and pregnancy complications, including intrauterine growth r
211 as been implicated as a pathogenic factor in pregnancy complications, including IUGR; however, the ro
212 ancy; impaired remodeling is associated with pregnancy complications, including late miscarriage, pre
214 s erythematosus carries an increased risk of pregnancy complications, including preeclampsia and feta
215 insight into the pathogenesis of many human pregnancy complications, including preeclampsia, intraut
216 ental inflammatory responses associated with pregnancy complications, including spontaneous preterm d
217 In addition to immediate implications for pregnancy complications, increasing evidence implicates
220 cally, gestational diabetes was considered a pregnancy complication involving treatment of rising gly
221 ed data from the International Prediction of Pregnancy Complications (IPPIC) Network of studies on pr
222 apping functions, the increased incidence of pregnancy complications is specific for EP300 mutations.
223 o maternal hyperglycemia, a common metabolic pregnancy complication, is of public health significance
225 used to prevent not only the development of pregnancy complications like gestational diabetes that i
227 individuals at greater risk of diet-related pregnancy complications, low diet quality was pervasive
228 with elevated risk of wheeze, adjusting for pregnancy complications, maternal atopy, gestational age
229 Results suggest that common cardiometabolic pregnancy complications may influence child ASD-related
231 ould be regarded as an indicator of possible pregnancy complications, not necessarily as a sign of ad
232 , excessive levels of IFITMs may mediate the pregnancy complications observed during congenital infec
234 4; 95% confidence interval, 1.00-2.38), or a pregnancy complication (odds ratio, 1.78; 95% confidence
236 implications regarding neurodevelopment and pregnancy complications of the mother following prenatal
237 nd micronutrient supplements may reduce some pregnancy complications or impact women's ability to acc
238 eases (adjusted OR 3.69 [95% CI 1.78-7.66]), pregnancy complications or miscarriages (3.54 [1.47-8.55
243 tility and recurrent miscarriage, as well as pregnancy complications preeclampsia, fetal growth restr
245 body mass index, parity, medical conditions, pregnancy complications, prenatal smoking, and prenatal
246 h (five [19%]), pregnancy outcomes including pregnancy complications, preterm birth, or birthweight (
248 the matching effect could be associated with pregnancy complications rather than with schizophrenia p
249 n had a lower risk of pre-eclampsia-a common pregnancy complication related to higher CVD risk among
251 also increase the risk of placenta-mediated pregnancy complications (severe pre-eclampsia, small-for
252 ated disease, previous spontaneous abortion, pregnancy complications, smoking (since 1991), and body
256 heterogeneity employed for the mitigation of pregnancy complications such as fetal growth restriction
257 Prenatal cytomegalovirus infection may cause pregnancy complications such as intrauterine growth rest
258 lacentation has been noticed in a variety of pregnancy complications such as miscarriage, early-onset
259 pressed by dNK reduces development of severe pregnancy complications such as miscarriages and preterm
260 placenta is crucial for our understanding of pregnancy complications such as preeclampsia and fetal g
265 blast differentiation has been implicated in pregnancy complications, such as pre-eclampsia and gesta
267 immunologic homeostasis are associated with pregnancy complications, such as preeclampsia and intrau
268 al placentation and the later development of pregnancy complications, such as preeclampsia, fetal gro
269 gnant surgeons are more likely to have major pregnancy complications, such as preterm delivery, intra
271 e infiltration may be an underlying cause of pregnancy complications, such as preterm labor or preecl
272 nherited thrombophilia and placenta-mediated pregnancy complications, such as recurrent pregnancy los
275 STRACT: Chronic fetal hypoxaemia is a common pregnancy complication that may arise from maternal, pla
276 uterine infections have been associated with pregnancy complications that are also linked with increa
277 f of pregnancy, and no history of or current pregnancy complications that might have impaired fetal g
279 studies have investigated the combination of pregnancy complications that predict risk for cardiovasc
280 betes, obesity, and overweight are prevalent pregnancy complications that predispose offspring to neu
281 Complications (IPPIC) Network of studies on pregnancy complications; the full dataset comprised 94 s
282 f the relation of the occurrence of multiple pregnancy complications to CVD death over 5 decades in a
285 hat maternal inflammation can lead to severe pregnancy complications via a mechanism that involves in
295 estational diabetes mellitus (GDM), a common pregnancy complication which has short-term and long-ter
299 processes that link the occurrence of these pregnancy complications with adverse child outcomes; alt
300 rations during pregnancy are associated with pregnancy complications with recognized later-life cardi